Back to Search
CAROLE BARISH, MD
MD
Pediatrics Physician
NPI: 1740550268Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
GFE23805(CA)
Research & Publications (7)
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.
PMID 17206633·Inflamm Bowel Dis·2007
4-observational
Tolerability and patient acceptance of sodium phosphate tablets compared with 4-L PEG solution in colon cleansing: combined results of 2 identically designed, randomized, controlled, parallel group, multicenter phase 3 trials.
PMID 17198066·J Clin Gastroenterol·2007
3-trial
Safety and colon-cleansing efficacy of a new residue-free formulation of sodium phosphate tablets.
PMID 17029618·Am J Gastroenterol·2006
3-trial
A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.
PMID 16804392·Inflamm Bowel Dis·2006
3-trial
Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease.
PMID 12269969·Aliment Pharmacol Ther·2002
3-trial
Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease.
PMID 11876692·Aliment Pharmacol Ther·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2545 HIDDEN VALLEY PL
LA JOLLA, CA 92037 - Phone
- (858) 459-6520
Quick Facts
- NPI
- 1740550268
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile